Ablynx Competitors and Similar CompaniesClear all
CytomX Therapeutics's competitors and similar companies include Genfit.
 CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. |  Genfit GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs. | |
Founding Date | Founding Date 2008 | Founding Date 1999 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations South San Francisco, US HQ | Locations Loos, FR HQ Cambridge, US |
Employees | Employees 15815% increase | Employees 180 |
Valuation ($) | Valuation ($) 78 m | Valuation ($) 280.8 m |
Financial | ||
Revenue (est.) | Revenue (est.) $76.2m (FY, 2025) | Revenue (est.) €65.4m (FY, 2025) |
Net income | Net income ($17.4m) (FY, 2025) | Net income (€86m) (FY, 2025) |
Operating ⚠ | ||
Patents (Foreign) | Patents (Foreign) 4 (FY, 2016) | Patents (Foreign) 450 (FY, 2019) |
Patents (US) | Patents (US) 13 (FY, 2016) | Patents (US) 28 (FY, 2019) |
For sources of this data, please see the company profile
View Company Profiles
Genfit
HQ
Loos, FR
Employees
180
GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.
View company